What is NDC 76420-856?

76420-856 is the product NDC for tadalafil, Tadalafil 10 mg/1 tablet, film coated, listed with the FDA by Asclemed USA, Inc.. It has 5 package NDCs, shown above in 10- and 11-digit form.

Asclemed USA, Inc., NDC labeler code 76420. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for tadalafil?

242 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

tadalafil NDC 76420-856 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)76420-856Labeler and product segments. Claims need a package NDC.

Product NDC at billing width76420-0856Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
76420-856-01	7642008560176420085601	100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (76420-856-01)Marketed from Jan 28, 2025
76420-856-05	7642008560576420085605	500 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (76420-856-05)Marketed from Jan 28, 2025
76420-856-30	7642008563076420085630	30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (76420-856-30)Marketed from Jan 28, 2025
76420-856-60	7642008566076420085660	60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (76420-856-60)Marketed from Jan 28, 2025
76420-856-90	7642008569076420085690	90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (76420-856-90)Marketed from Jan 28, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): tadalafil
Generic name (nonproprietary): tadalafil
Active ingredients: Tadalafil — 10 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Asclemed USA, Inc.NDC labeler code 76420
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 209250
Marketing start: Mar 26, 2019
Listing expires: Dec 31, 2027
Other FDA classes: Phosphodiesterase 5 Inhibitors (Mechanism)
Identifiers: Product ID 76420-856_38689a7c-8af1-e4b0-e063-6394a90a94d8SPL ID 38689a7c-8af1-e4b0-e063-6394a90a94d8SPL set ID fa547e3d-455a-4926-9fd9-349930898502RxCUI 402019, 403957, 484814, 757707UNII 742SXX0ICT
Pharmacologic class: Phosphodiesterase 5 Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N476420085601 followed by a unit qualifier and the quantity

Package 76420-0856-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 25, 2025.

Indications (excerpt from the label)

Tadalafil Tablets are phosphodiesterase 5 (PDE5) inhibitor indicated for the treatment of: erectile dysfunction (ED) ( 1.1 ) the signs and symptoms of benign prostatic hyperplasia (BPH) ( 1.2 ) ED and the signs and symptoms of BPH (ED/BPH) ( 1.3 ) If Tadalafil Tablets are used with finasteride to initiate BPH treatment, such use is recommended for up to 26 weeks ( 1.4 ). 1.1 Erectile Dysfunction Tadalafil Tablets are indicated for the treatment of erectile dysfunction (ED). 1.2 Benign Prostatic Hyperplasia Tadalafil Tablets are indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH). 1.3 Erectile Dysfunction and Benign Prostatic Hyperplasia Tadalafil Table…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 76420-856

What is NDC 76420-856?: 76420-856 is the product NDC for tadalafil, Tadalafil 10 mg/1 tablet, film coated, listed with the FDA by Asclemed USA, Inc.. It has 5 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: tadalafil.
What is the active ingredient?: Tadalafil.
Who is the labeler?: Asclemed USA, Inc., NDC labeler code 76420. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for tadalafil?: 242 other product NDCs are listed under this name. See all tadalafil NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other tadalafil NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Tadalafil	Tadalafil 2.5 mg/1	Tablet, Film coatedOral	NorthStar Rx, LLC	72603-781	72603-0781-01
Tadalafil	Tadalafil 5 mg/1	Tablet, Film coatedOral	NorthStar Rx, LLC	72603-782	72603-0782-01
Tadalafil	Tadalafil 10 mg/1	Tablet, Film coatedOral	NorthStar Rx, LLC	72603-783	72603-0783-01
Tadalafil	Tadalafil 20 mg/1	Tablet, Film coatedOral	NorthStar Rx, LLC	72603-784	72603-0784-01
Tadalafil	Tadalafil 5 mg/1	TabletOral	REMEDYREPACK INC.	70518-4605	70518-4605-00
tadalafil	Tadalafil 20 mg/1	Tablet, Film coatedOral	Preferred Pharmaceuticals Inc.	68788-4083	68788-4083-0168788-4083-0368788-4083-07
Tadalafil	Tadalafil 20 mg/1	Tablet, Film coatedOral	A-S Medication Solutions	50090-8039	50090-8039-0050090-8039-0150090-8039-02
Tadalafil	Tadalafil 2.5 mg/1	Tablet, Film coatedOral	Umedica Laboratories USA Inc.	60290-027	60290-0027-0160290-0027-0260290-0027-03+1 more
Tadalafil	Tadalafil 5 mg/1	Tablet, Film coatedOral	Umedica Laboratories USA Inc.	60290-028	60290-0028-0160290-0028-0260290-0028-03+1 more
Tadalafil	Tadalafil 10 mg/1	Tablet, Film coatedOral	Umedica Laboratories USA Inc.	60290-029	60290-0029-0160290-0029-0260290-0029-03+1 more

All 243 tadalafil NDCs

Other NDCs under ANDA 209250

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 209250
Product	Strength	Form · route	Labeler	Product NDC
tadalafil	Tadalafil 2.5 mg/1	Tablet, Film coatedOral	Unichem Pharmaceuticals (USA), Inc.	29300-286
tadalafil	Tadalafil 5 mg/1	Tablet, Film coatedOral	Unichem Pharmaceuticals (USA), Inc.	29300-287
tadalafil	Tadalafil 10 mg/1	Tablet, Film coatedOral	Unichem Pharmaceuticals (USA), Inc.	29300-288
tadalafil	Tadalafil 20 mg/1	Tablet, Film coatedOral	Unichem Pharmaceuticals (USA), Inc.	29300-289
tadalafil	Tadalafil 10 mg/1	Tablet, Film coatedOral	Redpharm Drug	67296-2237
tadalafil	Tadalafil 5 mg/1	Tablet, Film coatedOral	NuCare Pharmaceuticals,Inc.	68071-3586
tadalafil	Tadalafil 20 mg/1	Tablet, Film coatedOral	NuCare Pharmaceuticals,Inc.	68071-3777
tadalafil	Tadalafil 20 mg/1	Tablet, Film coatedOral	Preferred Pharmaceuticals Inc.	68788-4083
tadalafil	Tadalafil 5 mg/1	Tablet, Film coatedOral	Proficient Rx LP	71205-754
tadalafil	Tadalafil 5 mg/1	Tablet, Film coatedOral	Bryant Ranch Prepack	71335-2467
tadalafil	Tadalafil 20 mg/1	Tablet, Film coatedOral	Bryant Ranch Prepack	71335-2583
tadalafil	Tadalafil 10 mg/1	Tablet, Film coatedOral	Bryant Ranch Prepack	71335-3175
tadalafil	Tadalafil 2.5 mg/1	Tablet, Film coatedOral	Asclemed USA, Inc.	76420-854
tadalafil	Tadalafil 5 mg/1	Tablet, Film coatedOral	Asclemed USA, Inc.	76420-855
tadalafil	Tadalafil 20 mg/1	Tablet, Film coatedOral	Asclemed USA, Inc.	76420-857
tadalafil	Tadalafil 20 mg/1	Tablet, Film coatedOral	Proficient Rx LP	82804-112
tadalafil	Tadalafil 10 mg/1	Tablet, Film coatedOral	Proficient Rx LP	82804-224